title: First use of a drug-eluting balloon in the treatment of acute renal artery occlusion and in-stent restenosis.
abstract: In-stent restenosis in a renal artery (RA) of a solitary functioning kidney is a serious complication of RA stenting. Drug-eluting balloons (DEB) have emerged as a novel way to manage restenosis. In this paper, the authors reported the first use of a DEB in the treatment of severe in-stent restenosis and thrombosis of a drug-eluting stent deployed in a RA. The patient presented with oligo-anuria and a serum creatinine (Scr) of 9 mg/dL that improved back to baseline of 2 mg/dL after the successful procedure. The optimal use of DEB in similar cases will have to be determined by larger clinical trials.
authors.affiliation: Division of Nephrology, American University of Beirut, Beirut, Lebanon.
authors.forename: Houssam S
authors.initials: HS
authors.lastname: Itani
authors.forename: Walid A
authors.initials: WA
authors.lastname: Mudawwar
authors.forename: Bassem Y
authors.initials: BY
authors.lastname: Tanios
authors.forename: Samir E
authors.initials: SE
authors.lastname: Alam
authors.forename: Fady F
authors.initials: FF
authors.lastname: Haddad
mesh_terms: D000800:Angioplasty, Balloon; D016503:Drug Delivery Systems; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D012077:Renal Artery; D012078:Renal Artery Obstruction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator